Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

CBO: Senate’s ACA repeal bill would destabilize some markets, increase deductibles

Some 22 million more people would be uninsured by 2026, deductibles and out-of-pocket costs would sharply rise while premiums would be lower and certain markets could be unstable if the Senate’s version of an Affordable Care Act repeal-and-replace plan becomes law, according to the Congressional Budget Office.

Alexa voice technology makes its way into hospitals

The Amazon Echo, home to Alex voice software, can do more than remind people of their next appointment. Hospitals around the nation are adding the technology to their wish lists with the aim of improving patient outcomes both in and out of the hospital.

Six-month insurance lockout penalty added to Senate ACA repeal bill

Four days after they first released it publicly, Senate Republicans have made a change to their version on Affordable Care Act repeal-and-replace legislation, adding a “continuous coverage” provision to try and discourage people from canceling their insurance plans.

Thumbnail

HFMA 2017: Experian’s Nicole Rogas says systems risk ‘financial distress’ if married to old RCM ways

An ever-changing world of reimbursement can be frustrating for those involved in revenue cycle management (RCM). Being too set in your ways to change, however, is one of the most common strategic mistakes seen by Nicole Rogas, MBA, senior vice president of sales at Experian Health.

Deloitte Showcases Family of Products for Health Care Providers and Announces Launch of Care Intellect

This year at the HFMA Annual National Institute, Deloitte will be showcasing its suite of provider margin improvement analytics services and products. This family of products for health care providers includes the ConvergeHEALTH Provider Intellect suite and LaborWise, Deloitte's workforce-focused analytics solution that identifies labor overspend.

Thumbnail

HFMA 2017: ACA repeal bills pose credit risk to hospitals

Whether Republicans’ version of an Affordable Care Act repeal-and-replace bill looks like the House-passed American Health Care Act (AHCA) or the Senate’s Better Care Reconciliation Act (BCRA), it would have a negative impact on the credit ratings of nonprofit hospitals, according to Fitch Ratings.

Thumbnail

HFMA 2017: Affiliations, not acquisitions, may be path to value-based care

Transitioning to value-based care and taking on risk is often cited as one of the drivers of the consolidation trend throughout healthcare. Some systems, however, are beginning to look at partnerships more “holistically,” according to Kaufman Hall managing director Anu Singh, MBA, by pursuing creative affiliations to enhance their capabilities rather than a merger or acquisition.

Thumbnail

The hot topics of HFMA 2017

In a year with new payment tracks for Medicare, additional bumps in the road on the path to value-based care and—potentially—an overhaul of health insurance coverage coming through Congress, what are healthcare finance leaders going to be focused on at this year’s conference?

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup